RU2005136382A - Способ получения никотинальдегидов - Google Patents

Способ получения никотинальдегидов Download PDF

Info

Publication number
RU2005136382A
RU2005136382A RU2005136382/04A RU2005136382A RU2005136382A RU 2005136382 A RU2005136382 A RU 2005136382A RU 2005136382/04 A RU2005136382/04 A RU 2005136382/04A RU 2005136382 A RU2005136382 A RU 2005136382A RU 2005136382 A RU2005136382 A RU 2005136382A
Authority
RU
Russia
Prior art keywords
lialh
oet
nicotinic acid
starting
morpholinamide
Prior art date
Application number
RU2005136382/04A
Other languages
English (en)
Other versions
RU2339619C2 (ru
Inventor
Хайнц-Германн БОКЕЛЬ (DE)
Хайнц-Германн Бокель
Мике БРАНДНЕР (DE)
Мике БРАНДНЕР
Лудвиг ГАНТЦЕРТ (DE)
Лудвиг ГАНТЦЕРТ
Ральф КНИРИМЕ (DE)
Ральф КНИРИМЕ
Original Assignee
Мерк Патент ГмбХ (DE)
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент ГмбХ (DE), Мерк Патент Гмбх filed Critical Мерк Патент ГмбХ (DE)
Publication of RU2005136382A publication Critical patent/RU2005136382A/ru
Application granted granted Critical
Publication of RU2339619C2 publication Critical patent/RU2339619C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/48Aldehydo radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Claims (10)

1. Способ получения никотинальдегидов реакцией восстановления, который характеризуется тем, что в качестве исходных эдуктов в реакции восстановления используют соответствующие морфолинамиды никотиновой кислоты.
2. Способ по п.1, отличающийся тем, что исходными эдуктами являются морфолинамиды никотиновой кислоты формулы I
Figure 00000001
в которой R1', R1" каждый, независимо друг от друга, представляет собой Н, Hal, A, ОА, CH2R2 или Ar;
R2 представляет собой ОА или NA2;
А представляет собой неразветвленный или разветвленный алкил, содержащий 1-10 атомов углерода, в которой одна или две СН2 группы могут быть заменены атомами О или S и/или -СН=СН- группами и/или также 1-7 атомов водорода могут быть заменены F;
Ar представляет собой ненасыщенную, частично или полностью насыщенную, моно- или полициклическую гомо- или гетероциклическую систему с гетероатомами О, N, S, которая незамещена или моно- или полизамещена Hal, А, ОА, NA2, NO2, NASO2A, SO2NA, SO2A; и
Hal представляет собой F, Cl, Br или I.
3. Способ по п.1 или 2, отличающийся тем, что применяемым исходным эдуктом является морфолинамид 5-(4-фторфенил)никотиновой кислоты.
4. Способ по п.1 или 2, отличающийся тем, что применяемым исходным эдуктом является морфолинамид 5-бромпиридин-3-карбоновой кислоты.
5. Способ по п.1 или 2, отличающийся тем, что в качестве восстанавливающего агента применяют LiAlH(OEt)3, LiAlH2(OEt)2 или LiAlH3(OEt).
6. Способ по п.3, отличающийся тем, что в качестве восстанавливающего агента применяют LiAlH(OEt)3, LiAlH2(OEt)2 или LiAlH3(OEt).
7. Способ по п.4, отличающийся тем, что в качестве восстанавливающего агента применяют LiAlH(OEt)3, LiAlH2(OEt)2 или LiAlH3(OEt).
8. Применение морфолинамидов никотиновой кислоты в реакции восстановления для получения соответствующих никотинальдегидов.
9. Применение по п.8, в котором морфолинамиды никотиновой кислоты соответствуют формуле I по п.1 и радикалы R1' и R1" имеют значения, указанные в п.1.
10. Исходные эдукты формулы I по п.2, выбранные из группы, включающей
а) морфолинамид 5-(4-фторфенил)никотиновой кислоты,
б) морфолинамид 5-бромникотиновой кислоты.
RU2005136382/04A 2003-04-24 2004-03-27 Способ получения никотинальдегидов RU2339619C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10318690.5 2003-04-24
DE10318690A DE10318690B3 (de) 2003-04-24 2003-04-24 Verfahren zur Herstellung von Nicotinaldehyden

Publications (2)

Publication Number Publication Date
RU2005136382A true RU2005136382A (ru) 2006-06-10
RU2339619C2 RU2339619C2 (ru) 2008-11-27

Family

ID=33154397

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005136382/04A RU2339619C2 (ru) 2003-04-24 2004-03-27 Способ получения никотинальдегидов

Country Status (16)

Country Link
US (1) US7528256B2 (ru)
EP (1) EP1615891B1 (ru)
JP (1) JP2006524196A (ru)
KR (1) KR101106621B1 (ru)
CN (1) CN100355730C (ru)
AR (1) AR044065A1 (ru)
AU (1) AU2004232454B2 (ru)
BR (1) BRPI0409644B1 (ru)
CA (1) CA2523190C (ru)
DE (1) DE10318690B3 (ru)
ES (1) ES2426412T3 (ru)
HK (1) HK1087111A1 (ru)
MX (1) MXPA05011253A (ru)
RU (1) RU2339619C2 (ru)
WO (1) WO2004094383A1 (ru)
ZA (1) ZA200509495B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5807955B2 (ja) * 2011-12-15 2015-11-10 国立大学法人横浜国立大学 植物用抵抗性誘導剤、植物の抵抗性誘導方法、及び植物病害の予防方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2994182B2 (ja) * 1992-07-23 1999-12-27 石原産業株式会社 アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
US6521618B2 (en) * 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
AR035851A1 (es) * 2000-03-28 2004-07-21 Wyeth Corp 3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas
SI1427724T1 (sl) * 2001-09-19 2006-10-31 Merck Patent Gmbh Nova uporaba substituiranih aminometil-kromanov

Also Published As

Publication number Publication date
ZA200509495B (en) 2009-03-25
AU2004232454B2 (en) 2010-02-25
CA2523190A1 (en) 2004-11-04
AU2004232454A1 (en) 2004-11-04
EP1615891A1 (de) 2006-01-18
EP1615891B1 (de) 2013-06-19
KR101106621B1 (ko) 2012-01-20
CA2523190C (en) 2012-01-24
CN100355730C (zh) 2007-12-19
AR044065A1 (es) 2005-08-24
US20060199965A1 (en) 2006-09-07
KR20060006056A (ko) 2006-01-18
BRPI0409644B1 (pt) 2019-01-22
RU2339619C2 (ru) 2008-11-27
ES2426412T3 (es) 2013-10-23
JP2006524196A (ja) 2006-10-26
DE10318690B3 (de) 2004-11-11
US7528256B2 (en) 2009-05-05
WO2004094383A1 (de) 2004-11-04
BRPI0409644A (pt) 2006-04-25
CN1777587A (zh) 2006-05-24
MXPA05011253A (es) 2005-12-14
HK1087111A1 (en) 2006-10-06

Similar Documents

Publication Publication Date Title
RU2403251C2 (ru) Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70
RU2488582C2 (ru) Бициклозамещенные азопроизводные пиразолона, способ их получения и фармацевтическое применение
RU2417993C2 (ru) Замещенные 2-хинолилоксазолы, пригодные в качестве ингибиторов фдэ4
RU2363700C2 (ru) Производные хинуклидина и фармацевтические композиции, содержащие их
RU2009141611A (ru) Способ получения амидного соединения
AU2018271293A1 (en) 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
RU2368608C2 (ru) Производные пиперидина в качестве модуляторов хемокинового рецептора ccr5
MX342806B (es) Compuestos y método para reducir el ácido úrico.
JP2018511647A5 (ru)
RU2001116117A (ru) Новые пиперазиновые и пиперидиновые соединения
TW200604175A (en) Ortho substituted aryl or heteroaryl amide compounds
MY142807A (en) Benzimidazole derivative and use thereof.
RU2008145102A (ru) Синтез ациламиноалкениленамидов, пригодных в качестве антагонистов вещества р
RU2010102137A (ru) Способ получения пиразолов
AR016387A1 (es) Compuestos que inhiben la adhesion de leucocitos intermediada por vla-4, metodo para adherir vla-4 en una muestra biologica, composicion farmaceutica,metodo de tratamiento con dichos compuestos
TW200713365A (en) Electrolyte solution for electrochemical device and electrochemical device using the same
NO20063681L (no) Aryloksyalkylkarbamattype derivater, fremgangsmate for fremstilling derav og anvendelse av derivatene i terapeutiske midler
CA2324418A1 (en) Novel opiate compounds, methods of making and methods of use
RU2002107318A (ru) Новые фенилпиперазины
MX2010001774A (es) Pirrolidin aril-eteres como antagonistas de receptores de nk3.
JP2008519099A5 (ru)
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
RU2002133458A (ru) Соединения пиперазина и пиперидина
DE69524103D1 (de) Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen
RU2005136382A (ru) Способ получения никотинальдегидов

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20210328